Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04750798 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias

Study acronym: SECURE
StatusRecruiting
PhaseNot specified
Started2021-02-22
View on ClinicalTrials.gov ↗
The purpose of this study is to prospectively collect clinical data evaluating the ongoing safety and performance during routine-use standard cardiac arrhythmia mapping and/or ablation procedures while using commercial Biosense Webster Inc. (BWI) medical devices. Data generated from the study will be used to confirm safety and performance of BWI medical devices in the marketed phase and to expand the body of evidence on the use of these devices and techniques in treatment of cardiac arrhythmias.

Amendment record

Amended 58 times since 2021-02-08; most recent filed 2026-08-27. The 50 most recent of 59 record versions are listed below. See every version on ClinicalTrials.gov ↗

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2026-08-27
Amendment Study Status, Contacts/Locations v58
2026-07-02
Amendment Study Status, Contacts/Locations v57
2026-06-04
Amendment Study Status, Contacts/Locations v56
2026-05-07
Amendment Study Status v55
2026-04-09
Amendment Study Status, Contacts/Locations v54
2026-03-12
Amendment Study Status, Contacts/Locations v53
2026-02-12
Amendment Study Status, Contacts/Locations v52
2026-01-15
Amendment Study Status, Contacts/Locations v51
2025-11-19
Amendment Study Identification, Study Status, Conditions, Study Design, Arms and Interventions, Outcome Measures, Contacts/Locations, IPDSharing v50
2025-10-09
Amendment Study Status, Contacts/Locations v49
2025-09-11
Amendment Study Status v48
2025-07-18
Amendment Study Status, Contacts/Locations v47
2025-07-17
Amendment Study Status v46
2025-05-22
Amendment Study Status v45
2025-04-24
Amendment Study Status v44
2025-04-01
Amendment Study Status, Contacts/Locations v43
2025-03-29
Amendment Study Status v42
2025-02-28
Amendment Study Status, Contacts/Locations v41
2025-02-06
Amendment Study Status, Contacts/Locations v40
2025-01-08
Amendment Study Status v39
2024-12-05
Amendment Study Status v38
2024-12-04
Amendment Study Status v37
2024-10-08
Amendment Study Status, Contacts/Locations v36
2024-09-10
Amendment Study Status, Contacts/Locations v35
2024-08-13
Amendment Study Status, Contacts/Locations v34
2024-07-16
Amendment Study Status, Contacts/Locations v33
2024-06-18
Amendment Study Status v32
2024-05-21
Amendment Study Status v31
2024-04-19
Amendment Study Status, Arms and Interventions, Outcome Measures, Contacts/Locations v30
2024-02-27
Amendment Study Status, Contacts/Locations v29
2024-02-12
Amendment Study Status v28
2024-01-12
Amendment Study Status, Outcome Measures, Contacts/Locations v27
2023-05-30
Amendment Study Status, Contacts/Locations v26
2023-05-03
Amendment Study Status, Contacts/Locations v25
2023-04-12
Amendment Study Status v24
2023-03-20
Amendment Study Status v23
2023-02-21
Amendment Study Status v22
2023-01-23
Amendment Study Status v21
2022-12-27
Amendment Study Status v20
2022-11-28
Amendment Study Status v19
2022-10-03
Amendment Study Status v18
2022-09-06
Amendment Study Status, Contacts/Locations v17
2022-08-08
Amendment Study Status, Contacts/Locations v16
2022-07-20
Amendment Study Status, Outcome Measures, Eligibility, Contacts/Locations v15
2022-06-13
Amendment Study Status, Contacts/Locations v14
2022-05-16
Amendment Study Status v13
2022-04-18
Amendment Study Status v12
2022-03-21
Amendment Study Status v11
2022-02-21
Amendment Study Status v10
2022-01-24
Amendment Study Status v9
Trial Details
NCT Number NCT04750798
Lead Sponsor Biosense Webster, Inc.
Conditions Arrhythmias, Cardiac
Enrollment 8,000 participants
Start Date 2021-02-22
Primary Completion 2036-12-31 (estimated)
Study Completion 2037-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-28